Alexandra Gaspar | Medicinal chemistry | Women Researcher Award

Published on by Environmental Scientists

Women Researcher Award

Alexandra Gaspar
Faculty of Sciences, University of Porto
Alexandra Gaspar
Affiliation Faculty of Sciences, University of Porto
Country Portugal
Scopus ID 7102545856
Documents 56
Citations 3157
h-index 25
Subject Area Medicinal chemistry
Event Environmental Scientists Award
ORCID
0000-0002-3892-4124

Alexandra Gaspar distinguished scholarly contributions and sustained academic achievements in scientific research and innovation. Alexandra Gaspar, affiliated with the Faculty of Sciences at the University of Porto, Portugal, has contributed to the advancement of medicinal chemistry through interdisciplinary research, publication activity, and scientific collaboration. Her academic profile reflects a sustained commitment to pharmaceutical sciences, molecular design, and medicinal chemistry applications relevant to environmental and biomedical challenges.[1]

Abstract

Alexandra Gaspar has established a recognized academic profile in medicinal chemistry, with scholarly activities emphasizing pharmaceutical innovation, bioactive molecular development, and interdisciplinary scientific applications. Her publication record, citation performance, and international research visibility demonstrate active engagement in medicinal and pharmaceutical sciences. Through contributions to peer-reviewed literature and collaborative scientific research, her work has supported ongoing developments in molecular therapeutics and chemical biology.[1][2]

Keywords

Women Researcher Award, Medicinal Chemistry, Pharmaceutical Sciences, Drug Discovery, Portugal, University of Porto, Molecular Design, Chemical Biology, Environmental Scientists Award, Scientific Research

Introduction

Medicinal chemistry remains an important interdisciplinary scientific field integrating chemistry, biology, and pharmaceutical sciences to support therapeutic development and molecular innovation. Researchers working in this area contribute to the design, synthesis, and evaluation of compounds with biological relevance. Alexandra Gaspar’s academic activities align with these objectives through investigations related to pharmaceutical compounds and medicinal chemistry methodologies. Her research profile reflects a combination of scientific productivity and international academic engagement within biomedical and pharmaceutical research domains.[1]

Research Profile

Alexandra Gaspar is associated with the Faculty of Sciences at the University of Porto in Portugal, where she has contributed to medicinal chemistry research and related pharmaceutical sciences. Her Scopus author profile documents 56 indexed publications with a citation count exceeding 3,100 and an h-index of 25, indicating notable scholarly visibility within the scientific community.[1]

Her academic work includes collaboration across interdisciplinary research environments and contributions to studies involving biologically active compounds, medicinal chemistry strategies, and molecular therapeutic investigations. These activities have contributed to the dissemination of scientific findings in peer-reviewed journals and international academic platforms.[2]

Research Contributions

The research contributions associated with Alexandra Gaspar encompass medicinal chemistry applications and pharmaceutical compound investigations. Her work has included the evaluation of molecular structures, chemical synthesis approaches, and studies associated with therapeutic and biological activities. Such investigations contribute to broader scientific understanding in medicinal and pharmaceutical chemistry.

  • Research involving medicinal chemistry and pharmaceutical sciences.
  • Contributions to peer-reviewed scientific publications and collaborative studies.
  • Participation in interdisciplinary molecular and therapeutic research initiatives.
  • Scientific dissemination through academic journals and international research platforms.

Publications

Alexandra Gaspar has contributed to scientific literature indexed in major academic databases. Selected publication themes include medicinal chemistry, molecular therapeutics, and pharmaceutical research methodologies. Her publication activity has contributed to citation visibility and scholarly engagement within the biomedical sciences community.[2]

  • Studies related to medicinal and pharmaceutical chemistry.
  • Research on biologically active molecules and therapeutic applications.

Research Impact

The citation performance and h-index associated with Alexandra Gaspar’s academic record indicate measurable scholarly influence within medicinal chemistry and pharmaceutical research. Citation metrics frequently reflect research visibility, scientific utilization, and interdisciplinary engagement. Her publication profile demonstrates continued participation in international scientific communication and collaborative knowledge production.[1]

Research impact in medicinal chemistry also extends to the development of methodologies and scientific approaches supporting biomedical and pharmaceutical innovation. Contributions within these areas are important for advancing scientific understanding and supporting future therapeutic investigations.

Award Suitability

Alexandra Gaspar’s scholarly profile aligns with the objectives of the Women Researcher Award due to her sustained research activity, publication performance, and scientific contributions within medicinal chemistry. Her academic engagement demonstrates participation in internationally relevant scientific research and interdisciplinary collaboration. The combination of publication productivity, citation impact, and institutional affiliation supports recognition within the Environmental Scientists Award framework.[1][2]

Conclusion

The Women Researcher Award article for Alexandra Gaspar presents a structured overview of her academic profile, research achievements, and scholarly visibility within medicinal chemistry. Her scientific activities demonstrate continued participation in pharmaceutical and biomedical research, with measurable citation impact and publication engagement. The profile reflects a contribution to scientific advancement consistent with international academic recognition standards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Alexandra Gaspar, Author ID 7102545856. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102545856
  2. ORCID. (n.d.). Alexandra Gaspar ORCID profile.
    https://orcid.org/0000-0002-3892-4124
  3. Gaspar, A., & Garrido, J. M. P. J. (2026). Unveiling RNA ligands: Harnessing NMR for hit generation.European Journal of Medicinal Chemistry.Β  https://www.sciencedirect.com/science/article/abs/pii/S0223523425012607?via%3Dihub
  4. Gaspar, A., Garrido, E. M. P. J., Borges, F., & Garrido, J. M. P. J. (2024). Biological and medicinal properties of natural chromones and chromanones. https://pubs.acs.org/doi/10.1021/acsomega.4c00771
  5. Silva, V. F. M., Silva, A., Garrido, E. M. P. J., Borges, F., Gaspar, A., & Garrido, J. M. P. J. (2024). Microencapsulation of the biocide benzisothiazolinone (BIT) by inclusion in methyl-Ξ²-cyclodextrin and screening of its antibacterial and ecotoxicity properties. https://www.mdpi.com/2305-6304/12/9/674

Haya Alzeer | Pharmacology | Research Excellence Award

Published on by Environmental Scientists

Research Excellence Award

Haya Alzeer
Saudi Food and Drug Authority

 

Haya Alzeer
Researcher Haya Alzeer
Affiliation Saudi Food and Drug Authority
Country Saudi Arabia
Scopus ID 57202029321
Citations 44 by 4 docments
h-index 3
Subject Area Pharmacology
Event International Environmental Scientists Award
ORCID
0009-0001-2301-4793

Haya Alzeer recognizes scholarly achievement, scientific contribution, and professional dedication within the fields of pharmacology and public health research. Haya Alzeer, affiliated with the Saudi Food and Drug Authority, has contributed to scientific investigations associated with pharmacological sciences, healthcare evaluation, and evidence-based analytical approaches. Her academic profile reflects continued engagement with peer-reviewed scientific literature and international research indexing platforms.[1]

Abstract

This academic recognition article documents the scholarly profile and research-oriented achievements of Haya Alzeer in the domain of pharmacology and health sciences. Her contributions are associated with scientific evaluation methodologies, healthcare-related analytical studies, and participation in indexed academic publishing platforms. The recognition under the International Environmental Scientists Award framework reflects the importance of interdisciplinary scientific advancement, regulatory awareness, and evidence-driven healthcare research. Indexed citation metrics and author profiling databases indicate sustained academic engagement and measurable research visibility within the broader scientific community.[1][2]

Keywords

Research Excellence Award, Pharmacology, Saudi Food and Drug Authority, Scientific Recognition, Academic Research, Healthcare Sciences, Scopus Indexed Research, Evidence-Based Medicine, Scientific Publications, International Environmental Scientists Award

Introduction

The advancement of pharmacological and healthcare sciences relies on systematic investigation, scientific transparency, and evidence-based methodologies. Academic recognition programs such as the Research Excellence Award are designed to acknowledge researchers who demonstrate scholarly productivity, scientific integrity, and measurable contributions to their disciplines. Haya Alzeer’s academic profile reflects participation in internationally indexed research activities and alignment with contemporary healthcare research standards.[1]

The Saudi Food and Drug Authority plays an important role in supporting scientific evaluation, healthcare safety, and regulatory research initiatives in Saudi Arabia. Researchers affiliated with such institutions contribute to the development of pharmacological assessments, public health monitoring, and analytical investigations relevant to healthcare systems and scientific governance.[3]

Research Profile

Haya Alzeer maintains a recognized academic presence through indexed scholarly databases and professional research identifiers. Her Scopus author profile documents research publications, citation records, and subject-area classification associated with pharmacology and healthcare sciences. The availability of an ORCID identifier further supports research transparency and author identity verification across international publishing systems.[1][4]

Research Contributions

The research contributions associated with Haya Alzeer involve participation in scientific studies relevant to healthcare assessment, pharmacological investigation, and evidence-based analytical practices. Such contributions support broader scientific objectives related to medication evaluation, healthcare quality assurance, and scientific data interpretation. The integration of indexed research findings into academic literature contributes to the advancement of reproducible scientific methodologies and interdisciplinary collaboration.[1]

Contemporary pharmacological research requires rigorous analytical standards, peer-review validation, and adherence to international publication ethics. Researchers operating within regulatory and healthcare institutions frequently contribute to the evaluation of safety frameworks, healthcare monitoring systems, and scientific reporting standards. These activities strengthen scientific reliability and public trust within healthcare-oriented research environments.[3]

Publications

Selected scholarly publications and indexed research records associated with Haya Alzeer demonstrate engagement with scientific publishing standards and peer-reviewed dissemination channels.[1]

Research Impact

Research impact may be evaluated through indexed citations, scholarly visibility, publication quality, and engagement with evidence-based scientific practices. Citation metrics associated with Haya Alzeer’s academic profile demonstrate that her published work has contributed to ongoing scholarly discussions within healthcare and pharmacological sciences.[1]

The broader significance of scientific contributions in pharmacology extends beyond publication metrics to include support for healthcare evaluation, regulatory science, and public health awareness. Research dissemination through internationally indexed databases facilitates collaboration, reproducibility, and long-term scientific accessibility.[2]

Award Suitability

Haya Alzeer’s scholarly profile demonstrates alignment with the objectives commonly associated with the Research Excellence Award. Her indexed publication record, citation performance, institutional affiliation, and scientific engagement collectively support recognition within an international academic award framework. Participation in peer-reviewed scientific activities and the maintenance of professional research identifiers further indicate commitment to research integrity and scholarly visibility.[1][4]

The International Environmental Scientists Award promotes interdisciplinary scientific recognition and encourages continued advancement in research quality, analytical rigor, and academic collaboration. Contributions connected to healthcare sciences and pharmacology remain essential to the development of evidence-based scientific systems and public health-oriented innovation.[6]

Conclusion

The Research Excellence Award article on Haya Alzeer presents a structured overview of her academic profile, institutional affiliation, indexed publication record, and measurable scholarly visibility within pharmacology and healthcare sciences. Through participation in peer-reviewed scientific activities and internationally recognized indexing systems, her work contributes to ongoing academic and healthcare-related research discussions. The documented research metrics and professional affiliations support recognition within a global scientific and academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Haya Alzeer, Author ID 57202029321. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57202029321
  2. ORCID. (n.d.). ORCID record for Haya Alzeer.https://orcid.org/0009-0001-2301-4793
  3. Saudi Food and Drug Authority. (n.d.). Scientific and regulatory activities in healthcare and pharmacology.https://www.sfda.gov.sa/en
  4. Haak, L. L., Fenner, M., Paglione, L., Pentz, E., & Ratner, H. (2012). ORCID: a system to uniquely identify researchers. Learned Publishing, 25(4), 259–264.https://doi.org/10.1087/20120404
  5. Alzeer, H., et al. (2023). Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray. Saudi Pharmaceutical Journal. https://pubmed.ncbi.nlm.nih.gov/37791036/

Dr. Geetha Vaskuri | Pharmaceutical Sciences | Women Researcher Award

Published on by Environmental Scientists

Dr. Geetha Vaskuri | Pharmaceutical Sciences | Women Researcher Award

Dr. Geetha Vaskuri, UTHSC, United States

🌟 Meet Dr. Geetha Vaskuri, a trailblazing researcher in Pharmaceutical Sciences from UTHSC, United States! With her groundbreaking work and dedication to advancing medical knowledge, Dr. Vaskuri has become a prominent figure in her field. Her innovative research and contributions have earned her a well-deserved spot in the running for the Women Researcher Award. πŸ‘©β€πŸ”¬πŸ’Š Her commitment to excellence and passion for improving health outcomes make her a standout candidate. We celebrate her remarkable achievements and look forward to seeing her continue to inspire and lead in pharmaceutical research! πŸŽ‰πŸ‘

PROFILE πŸ“

Googlescholar, Orcid

ACADEMIC CREDENTIALS πŸŽ“Β 

Dr. Geetha Vaskuri boasts impressive academic credentials in the field of Pharmaceutics. πŸŽ“ She earned her Ph.D. in Pharmaceutics from the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India, with a GPA of 8.17, graduating in 2023. 🌟 Before that, she completed her M.S. in Pharmaceutics at the same institution with a remarkable GPA of 9.42, from 2016 to 2018. πŸ“š Her academic journey began with a B.Pharmacy degree from Shri Vishnu College of Pharmacy, Bhimavaram, India, where she achieved a GPA of 7.75, from 2012 to 2016. πŸŽ‰ Her dedication to the field is evident through her outstanding academic achievements. πŸ‘

RESEARCH EXPOSURE πŸ”¬

Dr. Geetha Vaskuri has made significant contributions in pharmacokinetics and drug delivery. 🌟 Her research includes studying nanobodies in hFcRn mice using ELISA, analyzing CO-releasing compounds in plasma by HPLC, and measuring carboxyhemoglobin levels. πŸ’‰ Her Ph.D. dissertation, under Dr. Jitender Madan, focused on novel carrier systems for topical COX2 inhibitor delivery. πŸ’Š Her Master’s work, supervised by Dr. Nalini Shastri, assessed polymer properties in Dipyridamole solid dispersions. πŸ“š Dr. Vaskuri also fabricated pellets with a non-aqueous extrusion process and completed two industrial projects, including a patented novel drug form. πŸ”¬ She has reverse-engineered particle size analyses for major pharmaceutical companies. 🏷️

WORK EXPERIENCE πŸ’Ό

Dr. Geetha Vaskuri is currently serving as a Postdoctoral Research Scholar at the University of Tennessee Health Science Center (UTHSC) in Memphis, TN, USA, since May 2023 πŸŒŸπŸ”¬. With her expertise and dedication, Dr. Vaskuri is contributing significantly to advanced research in her field πŸ§¬πŸ”. Her role at UTHSC reflects her commitment to scientific excellence and innovation πŸš€πŸ’‘. As she continues to explore and expand her research horizons, Dr. Vaskuri’s work promises to make impactful strides in healthcare and science πŸ’ͺπŸ“š.

HANDS ON EXPERIENCE πŸ› οΈ

Dr. Geetha Vaskuri specializes in a range of advanced techniques and equipment essential for research and analysis. Her expertise includes Hot Melt Extrusion (HME), microfluidizer, extrusion-spheronizer, and ball mill. πŸ§ͺπŸ”¬ She also uses probe sonicator, high shear homogenizer, and texture analyzer for precise measurements. πŸŒ€πŸ’§ Dr. Vaskuri’s work involves rheometer, ultra centrifuge, and Roche friabilator, alongside Zetasizer and dissolution apparatus. πŸ§«πŸ“ Her skills extend to microscopy techniques like polarized microscopy, hot stage microscopy, and scanning electron microscope (SEM). πŸ”¬πŸ“Έ She employs HPLC, DSC, UV spectroscopy, FTIR, Multi-Mode Reader, Western blot apparatus, and more for comprehensive analysis. πŸ“ŠπŸ”¬

ACADEMIC ACHIEVEMENTS πŸ†

Dr. Geetha Vaskuri has an impressive academic and research background. πŸŽ“ She received the Senior Research Fellowship from the Department of Pharmaceuticals, Government of India, from August 2020 to December 2022. Prior to this, she was awarded the Junior Research Fellowship from the same department from August 2018 to July 2020. πŸ† Dr. Vaskuri excelled in competitive exams, securing All India Rank 1 in the NIPER JEE-2018 PhD entrance examination, and All India Rank 43 in the NIPER-JEE Masters 2016. She also achieved All India Rank 1 in the Manipal Entrance Test and scored 165/300 in the Central Universities CET 2016. πŸš€πŸ“š

HONORS & AWARDS πŸ₯‡

Dr. Geetha Vaskuri has been honored with the Young Researcher Award 2023 for her groundbreaking research on meloxicam-loaded solid lipid nanoparticles in chitosan gel for osteoarthritis in a rat model. πŸŒŸπŸ† She was nominated by the Department of Science & Technology, Government of India, to participate in the 72nd Lindau Nobel Laureate Meeting, focusing on Physiology and Medicine from June 25-30, 2023. πŸ…πŸ”¬ She secured 1st place for her oral presentation on β€œConsequence of lipid chain length and functional group on the permeation efficiency of topical SLN gel” at BITS Pilani, Hyderabad on November 25, 2022. πŸŽ€πŸ“ˆ Additionally, she received the Best Oral Presentation award for her work on β€œVersatility of film-forming topical dermal spray of meloxicam” at the 2nd International Conference on Pharmaceutics & Drug Delivery Systems, Dubai, UAE, from May 16-17, 2022. πŸŒπŸ’Š Financial assistance for this conference was provided by the SCIENCE & ENGINEERING RESEARCH BOARD (SERB), Department of Science & Technology, Government of India. πŸ’΅πŸ‘

WORKSHOPS & CONFERENCES πŸ“…

Dr. Geetha Vaskuri has an impressive track record in pharmaceutical research and education! 🌟 She presented her poster on β€œPharmacokinetic study of nanosota nanobodies in hFcRn mice” at the Midwest AViDD Center Workshop #4 in Houston, US, in March 2024. πŸ“Š In November 2022, she showcased her work on β€œTherapeutic Efficacy of Meloxicam Loaded Solid Lipid Nanoparticles Topical Gel in Managing Osteoarthritis in Rats” at Pharmacon 2022 in India. πŸ§ͺ Dr. Vaskuri has also coordinated workshops on advanced drug delivery techniques and participated in various conferences and workshops, including those focused on drug discovery, innovations, and quality management. πŸ’‘πŸ“š

PUBLICATIONS TOP NOTES πŸ“š

Cellulose based polymers in development of amorphous solid dispersions

Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges

Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update

Self healing hydrogels: A new paradigm immunoadjuvant for delivering peptide vaccine

Lipid nanoparticles in topical dermal drug delivery: Does chemistry of lipid persuade skin penetration?

Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems

Tuning Diffusion Permeability of an Anti-Retroviral Drug, Emtricitabine, via Multicomponent Crystallizations

SNAC for Enhanced Oral Bioavailability: An Updated Review

Film forming topical dermal spray of meloxicam attenuated pain and inflammation in carrageenan-induced paw oedema in Sprague Dawley rats

Does skin permeation kinetics influence efficacy of topical dermal drug delivery system?: Assessment, prediction, utilization, and integration of chitosan biomacromolecule for …